InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,583.39
(
0.19%
)
US TECH 100
19,932.40
(
0.20%
)
Dow Jones
39,413.66
(
0.18%
)
Brent Oil
84.68
(
-0.86%
)
Bitcoin
57,566.50
(
1.52%
)

Replies to post #603 on PROTALIX BIOTHERAPEUTICS, INC. (PLX)

Replies to #603 on PROTALIX BIOTHERAPEUTICS, INC. (PLX)

genisi

02/17/11 11:17 AM

#655 RE: genisi #603

Shire booked sales of $59M for Vpriv (velaglucerase for Gaucher) in Q410. Shire also sees very low switch-back to Cerezyme.